Study: Treatment for antibody-associated vasculitis is shifting from cyclophosphamide to rituximab – Healio

Study: Treatment for antibody-associated vasculitis is shifting from cyclophosphamide to rituximab – Healio

Study: Treatment for antibody-associated vasculitis is shifting from cyclophosphamide to rituximab – Healio
Published on 2017-09-25